Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
Prostate Cell News
Prostate Cell News is an online resource summarizing the latest prostate cell research.
The Anti-Diabetic PPARγ Agonist Pioglitazone Inhibits Cell Proliferation and Induces Metabolic Reprogramming in Prostate Cancer
[Molecular Cancer] The authors suggested that Pioglitazone reduces prostate cancer (PCa) cell proliferation and induces metabolic and epithelial changes, highlighting the potential of repurposing metabolic drugs for PCa therapy.
CASK Promotes Prostate Cancer Progression via Kinase-Dependent Activation of AKT
[International Journal of Biological Macromolecules] Researchers investigated the roles of calcium/calmodulin-dependent serine protein kinase in prostate cancer (PCa) progression, cell migration, and invasion. They found that CASK is up-regulated in PCa tissues of patients.
The PPARβ/CERK/C1P Signaling Pathway Is a Potential Mechanism by Which Antimony Exposure Promotes Prostate Cancer Cell Proliferation
[Ecotoxicology and Environmental Safety] To explore the relationship between antimony exposure and cell proliferation, scientists found that the level of ceramide-1-phosphate (C1P), one of the metabolites of ceramide, increased after antimony exposure, and C1P can promote the proliferation of prostate cancer cells and antagonize the apoptosis induced by ceramide.
Insights into the Cellular Lipid Cascade of Prostate Cells Explored Using Infrared Microspectroscopy
[Analyst] Fourier transform infrared imaging coupled with fluorescence microscopy was used to follow arachidonic acid metabolism in prostate cancer cell lines.
Sinularin Induces Autophagy-Dependent Cell Death by Activating ULK1 and Enhancing FOXO3-ATG4A Axis in Prostate Cancer Cells
[Scientific Reports] Scientists demonstrated that Sinularin triggers autophagy via two different mechanisms in prostate cancer cells.
Effects of the Mitoxantrone Thermosensitive Liposome Nanodelivery System on Prostate Cancer In Vivo and In Vitro
[Scientific Reports] Investigators prepared mitoxantrone thermosensitive liposome to enhance the targeting capability of liposomes and thus improve the therapeutic effect of the drug on prostate cancer.
Suppression of Cellular Proliferation in PC3 Prostate Cancer Cells by Green Tea Extract Through Induction of miR-34a Expression
[Food Science & Nutrition] Researchers evaluated the effects of green tea extract on suppression of cellular proliferation through testing the expression of miR-34a in PC3 prostate cancer cells.
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial
[World Journal of Clinical Oncology] Scientists hypothesized the BM-targeting alpha-emitter radium-223 dichloride (Ra223) could target subclinical bone disease and delay progression.
mRNA Vaccines for Prostate Cancer: A Novel Promising Immunotherapy
[Biochimica Et Biophysica Acta-Reviews On Cancer] Over the past few decades, various conventional therapeutic prostate cancer (PCa) vaccines based on cells, microbes, proteins, peptides, or DNA have been developed and tested in patients with advanced PCa.
The Prostate Cancer Foundation Awards More Than $6 Million to Promising Young Investigators to Advance Prostate Cancer Research
[Prostate Cancer Foundation (Business Wire)] The Prostate Cancer Foundation Awards More Than $6 Million to Promising Young Investigators to Advance Prostate Cancer Research
Identification of Druggable Genetic Targets for Prostate Cancer Risk Based on Mendelian Randomization and Single-Cell RNA Sequencing
[International Urology and Nephrology] Scientists identified several genetic targets associated with prostate cancer risk, highlighting the potential for targeted therapy.
Advances in Targeted Therapy for Metastatic Prostate Cancer
[Current Treatment Options In Oncology] The authors highlight the role of poly-ADP-ribose-polymerase inhibitors in metastatic prostate cancer, emerging strategies to target the androgen receptor, and innovative therapies aimed at cell surface proteins, including radioligand therapies, bispecific T cell engagers, and antibody–drug conjugates.
Published since 2010, Prostate Cell News compiles top scientific journal articles covering the characterization, behavior, and culturing of prostate cells. Additionally, our editorial team curates the latest press releases, technical advances, jobs, and events relevant to the prostate cell research community. Prostate Cell News saves scientists valuable time while keeping them informed in their field, facilitating the rapid exchange of cutting edge research updates and science news.
